Rapport Therapeutics, Inc. RAPP Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s change in accrued liabilities?
- Rapport Therapeutics, Inc. (RAPP) reported change in accrued liabilities of -$3.49M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s change in accrued liabilities changed year-over-year?
- Rapport Therapeutics, Inc.'s change in accrued liabilities decreased by 1154.7% year-over-year, from $331K to -$3.49M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.